Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
Bone Metastases
Brain Cancer
Business Management
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Genitourinary Cancers
Head & Neck Cancers
Hematologic Oncology
Immunotherapy in GU Cancers
Immunotherapy in Lung Cancer
Immunotherapy in Melanoma
Mantle Cell Lymphoma
Melanoma & Skin Cancer
Non-Hodgkin Lymphoma
Oncology Nursing News
Patient Resources
Sarcomas/TGCT
Special Reports in Personalized Cancer Care
Supportive Care
Online CME
Interactive Publications
SELECT A TOPIC
CURRENT VIEW
All Specialties
▲
Education ▲
Education ▼
Register
|
Login
Conference Coverage
Videos
NewsNetwork
OncLive
®
TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology
®
Neoadjuvant HER2+
More >>
OncLive TV: Nicholas J. Vogelzang, MD
<< Back to Our Featured Experts
Dr. Vogelzang Discusses PROSPECT Trial for Prostate Cancer
Dr. Vogelzang Discusses the Addition of Chemotherapy to ADT in Men With Prostate Cancer
Dr. Vogelzang Discusses the Prostate Health Cocktail
Dr. Vogelzang on Two Analyses of the ALSYMPCA Trial
Dr. Vogelzang Discusses First-Line Axitinib in mRCC
Dr. Vogelzang on Sequencing Abiraterone and Enzalutamide
Dr. Vogelzang Discusses the Cabozantinib Trial Design
Dr. Vogelzang Discusses Cabozantinib's Dose Size
Dr. Vogelzang Describes Cabozantinib's Side Effects
Dr. Vogelzang on Cabozantinib Clinical Trial Results
Dr. Vogelzang on XL184's Effect on Bone Metastases
Dr. Vogelzang Discusses Cabozantinib Trial Design
Oncology Specialists
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
Joseph Uberti, MD, PhD
Naoto Tada Ueno, MD, PhD, FACP
Katsuhiko Uesaka, MD, PhD
Susanna Ulahannan, MD
Michael Ulm, MD
Joseph M. Unger, MS, PhC
Michael Untch, MD, PhD
Santhosh Upadhyaya, MD
James Urbanic, MD
Saad Z. Usmani, MD
Saad Z. Usmani, MD, FACP
Robert G. Uzzo, MD
Robert G. Uzzo, MD, MBA, FACS
OncLive News Network On Location: ASH 2019 Day 1
Trending Now
Anti-BCMA, CD3 Agent CC-93269 Shows Promise for Heavily Pretreated Myeloma
Dr. Janice Mehnert on Why it's a Challenge to Identify Biomarkers for Immunotherapy
Dr. Camidge on the Evolution of Clinical Cancer Research
Third-Line Therapy for Pancreatic Cancer
Publications
Covering Every Angle of Oncology Practice. Click a cover below, to view more.
x
Subscribe